Critical Care Diagnostics Market - Top Companies and Manufacturers

  • Report ID: 5813
  • Published Date: Mar 05, 2024
  • Report Format: PDF, PPT

Companies Dominating the Critical Care Diagnostics Landscape

top-features-companies
    • Abbott
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • F. Hoffmann-La Roche Ltd
    • Danaher
    • BD
    • EKF Diagnostics
    • bioMérieux, Inc.
    • Siemens Healthcare Private Limited
    • Chembio Diagnostics, Inc.
    • Bayer AG

Browse Key Market Insights with Data Illustration:

In the News

  • Abbott obtained approval from the U.S. Food and Drug Administration (FDA) for the company's industry-leading life support system, CentriMag Blood Pump for use with the CentriMag System a type of life support for people whose heart and lungs are not working, and to enable physicians more time to make critical care decisions for their patients.
  • F. Hoffmann-La Roche Ltd. announced the launch of the next-generation qPCR system, LightCycler PRO System to enable a portfolio of more than 200 LightMix Modular research assays, and to meet clinical needs in molecular diagnostics and tackle public health issues in addition to enabling users to create their tests.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5813
  • Published Date: Mar 05, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The growing burden of cancer across the globe and the growing development of quick diagnostic tools are the major factors driving the growth of the market.

The market size of Critical Care Diagnostics is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2024-2036.

The major players in the market are F. Hoffmann-La Roche Ltd, Danaher, BD, EKF Diagnostics, bioMérieux, Inc., Siemens Healthcare Private Limited, Chembio Diagnostics, Inc., Bayer AG, and others.

The immunoproteins segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying